Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER
a study on High Blood Pressure
Summary
- Eligibility
- for people ages 18-85 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Reata Pharmaceuticals, Inc.
- ID
- NCT03068130
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated